Dr. Pornwaratt Niyomrattanakit

Maveta Co., Ltd

Established medical device import/distribution firm, securing Thai FDA approvals and supplier partnerships. Managed business planning, financials, and regulatory navigation.

Jetanin IVF, Bangkok

Dr. Pornwaratt provides executive oversight of Jetanin IVF’s genomics and molecular diagnostics operations, driving both scientific excellence and commercial growth. Under her leadership, the division achieved 400% profit margin growth. She has personally led the clinical implementation and IVD commercialization of next-generation sequencing (NGS), preimplantation genetic testing (PGT) and carrier screening translating cutting-edge genomic science into validated, revenue-generating diagnostic services. Her scientific expertise in molecular genetics, biophysical assays, and genomic data interpretation directly informs product development decisions and clinical service innovation. She oversees ISO 15189 accreditation, laboratory quality systems, and regulatory compliance, while building strategic alliances with global life science and IVD industry partners to expand the organization’s portfolio and international influence. She leads multi-year business planning, P&L ownership, and cross-functional stakeholder engagement across clinical, commercial, and regulatory domains.

Novartis Institute for Tropical Diseases, Singapore

As Principal Scientist, Dr. Pornwaratt led high-throughput molecular biology programs in support of drug discovery for tropical infectious diseases, demonstrating deep scientific proficiency in enzyme kinetics, cell-based assays, biophysical screening, and molecular genetics. She designed and validated assay platforms from early discovery through candidate selection, applying rigorous scientific judgment to complex experimental challenges. She established training frameworks and authored comprehensive SOPs that institutionalized scientific standards across the laboratory. Her postdoctoral work at this internationally recognized research institute sharpened her command of translational science—bridging fundamental molecular research with applied diagnostic and therapeutic development.